Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1474.608
  • -6.226-0.42%
Close Mar 18 16:00 ET
1482.520High1464.767Low
Constituent Stocks: 10Top Rising: A+0.50%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
AAgilent Technologies
123.1000.610+0.50%1.42M173.52M122.100122.490123.200121.42035.10B34.98B285.10M284.14M+1.71%+0.03%-8.95%-9.62%-11.64%-15.15%-8.37%0.78%0.50%28.2327.791.45%Diagnostics & Research
VRTXVertex Pharmaceuticals
512.230-1.530-0.30%1.34M685.49M513.075513.760516.500508.520131.54B131.13B256.79M255.99M+4.89%+5.35%+10.85%+9.16%+11.35%+24.52%+27.20%--0.52%LossLoss1.55%Biotechnology
BLUEbluebird bio
3.940-0.020-0.51%214.27K839.92K3.9503.9604.0103.80038.38M38.12M9.74M9.68M-0.51%+3.14%-44.66%-56.08%-59.71%-86.32%-52.76%--2.22%LossLoss5.30%Biotechnology
APLSApellis Pharmaceuticals
24.410-0.700-2.79%1.65M40.54M24.83025.11025.03024.1203.06B2.06B125.52M84.23M-4.35%-2.55%-13.38%-29.31%-25.40%-56.61%-23.50%--1.96%LossLoss3.62%Biotechnology
NTLAIntellia Therapeutics
9.190-0.390-4.07%3.11M28.59M9.4209.5809.4708.860951.33M899.82M103.52M97.91M-1.18%+1.04%-20.29%-30.01%-57.18%-66.42%-21.18%--3.18%LossLoss6.37%Biotechnology
CRSPCRISPR Therapeutics
40.970-1.850-4.32%1.93M79.32M42.67042.82042.67040.4003.51B3.44B85.77M83.93M-3.30%-5.71%-21.54%-8.20%-12.34%-42.68%+4.09%--2.30%LossLoss5.30%Biotechnology
EDITEditas Medicine
1.315-0.095-6.74%1.56M2.09M1.4101.4101.4401.310109.11M108.65M82.98M82.62M-10.54%-25.28%-24.43%-13.49%-64.07%-82.97%+3.54%--1.88%LossLoss9.22%Biotechnology
CRBUCaribou Biosciences
0.950-0.070-6.83%1.39M1.34M1.0301.0201.0500.95088.38M79.79M93.00M83.96M-11.19%-13.61%-33.08%-51.02%-49.98%-81.81%-40.23%--1.66%LossLoss9.80%Biotechnology
BEAMBeam Therapeutics
22.590-1.930-7.87%1.93M44.36M23.92024.52024.01022.5002.26B1.94B99.84M85.92M-14.48%-14.56%-32.55%-20.96%-8.62%-33.69%-8.91%--2.25%LossLoss6.16%Biotechnology
SGMOSangamo Therapeutics
0.846-0.164-16.23%11.73M10.17M0.9091.0100.9090.840190.13M171.56M224.71M202.76M-14.70%-1.58%-26.43%-70.00%-7.53%-0.58%-17.05%--5.79%LossLoss6.83%Biotechnology

News

Comments

Read more